San Diego, United States
Element Biosciences is pioneering efforts in the Biotechnology sector, with a specific focus on enhancing accessibility to biological tools. Established in 2017, this United States-based company aligns its operations across the Health Care and Life Sciences industries, backed by a clear mission encapsulated in its slogan: "Opening the world of biology to new possibilities".
The company's core value lies in its ability to innovate every fundamental element of a biological assay system. By offering affordable, high-quality data, Element Biosciences significantly improves the user experience for scientists, ultimately propelling the pace of scientific discovery. This strategic approach aids in democratizing advanced biological tools, making them more accessible to a wider audience.
Recently, the company bolstered its financial pathways with a substantial $175.00M Series E investment on 01 June 2026, led by renowned investor Samsung Electronics. This funding underscores strong investor confidence in their innovative solutions and their potential to drive significant impact across their core sectors.
Sphere Fluidics Limited
Iontek Molecular Diagnostics
